CHARACTERISING THE TUMOUR SUPPRESSIVE FUNCTION OF MYOEPITHELIAL CELL STEFIN A IN DUCTAL CARCINOMA IN SITU
Grant number: 1127754 | Funding period: 2019 - 2019
Ductal carcinoma in situ (DCIS) is a pre-invasive stage of breast cancer, whereby the tumour cells remain restrained by myoepithelial cells that surround breast ducts. Predicting which cases of DCIS will later develop invasive cancer is difficult, meaning that the majority of patients have treatment. Stefin A is a protease inhibitor in myoepithelial cells shown to block cancer invasion and we aim to test the function of this protein in DCIS and its potential as a prognostic marker.
Related publications (2)
High-content siRNA 3D co-cultures to identify myoepithelial cell-derived breast cancer suppressor proteins
Hendrika M Duivenvoorden, Natasha K Brockwell, Cameron J Nowell, Kaylene J Simpson, Belinda S Parker
Understanding how cancer cells interact with the surrounding microenvironment early in breast cancer development can provide insig..
Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion
Hendrika M Duivenvoorden, Jai Rautela, Laura E Edgington-Mitchell, Alex Spurling, David W Greening, Cameron J Nowell, Timothy J Molloy, Elizabeth Robbins, Natasha K Brockwell, Cheok Soon Lee-, Maoshan Chen, Anne Holliday, Cristina I Selinger, Min Hu, Kara L Britt, David A Stroud, Matthew Bogyo, Andreas Moeller, Kornelia Polyak, Bonnie F Sloane
Mammography screening has increased the detection of early pre-invasive breast cancers, termed ductal carcinoma in situ (DCIS), in..